MIRA
Price
$1.05
Change
-$0.01 (-0.94%)
Updated
Dec 23 closing price
64 days until earnings call
VRBCF
Price
$339.23
Change
-$42.77 (-11.20%)
Updated
Dec 12 closing price
Ad is loading...

MIRA vs VRBCF

Header iconMIRA vs VRBCF Comparison
Open Charts MIRA vs VRBCFBanner chart's image
MIRA Pharmaceuticals
Price$1.05
Change-$0.01 (-0.94%)
Volume$239.52K
CapitalizationN/A
Virbac SA
Price$339.23
Change-$42.77 (-11.20%)
Volume$23
CapitalizationN/A
MIRA vs VRBCF Comparison Chart
Loading...
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIRA vs. VRBCF commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIRA is a Hold and VRBCF is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (MIRA: $1.05 vs. VRBCF: $339.23)
Brand notoriety: MIRA and VRBCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MIRA: 12% vs. VRBCF: 51%
Market capitalization -- MIRA: $16.26M vs. VRBCF: $2.61B
MIRA [@Pharmaceuticals: Major] is valued at $16.26M. VRBCF’s [@Pharmaceuticals: Major] market capitalization is $2.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIRA’s FA Score shows that 0 FA rating(s) are green whileVRBCF’s FA Score has 0 green FA rating(s).

  • MIRA’s FA Score: 0 green, 5 red.
  • VRBCF’s FA Score: 0 green, 5 red.
According to our system of comparison, VRBCF is a better buy in the long-term than MIRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIRA’s TA Score shows that 3 TA indicator(s) are bullish while VRBCF’s TA Score has 1 bullish TA indicator(s).

  • MIRA’s TA Score: 3 bullish, 4 bearish.
  • VRBCF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, VRBCF is a better buy in the short-term than MIRA.

Price Growth

MIRA (@Pharmaceuticals: Major) experienced а -4.55% price change this week, while VRBCF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.75%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was -2.62%.

Reported Earning Dates

MIRA is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.75% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRBCF($2.61B) has a higher market cap than MIRA($16.3M). VRBCF YTD gains are higher at: 17.788 vs. MIRA (0.000). VRBCF has higher annual earnings (EBITDA): 213M vs. MIRA (-6.82M). VRBCF has more cash in the bank: 176M vs. MIRA (5.87M). MIRA has less debt than VRBCF: MIRA (109K) vs VRBCF (148M). VRBCF has higher revenues than MIRA: VRBCF (1.15B) vs MIRA (0).
MIRAVRBCFMIRA / VRBCF
Capitalization16.3M2.61B1%
EBITDA-6.82M213M-3%
Gain YTD0.00017.788-
P/E RatioN/A29.33-
Revenue01.15B-
Total Cash5.87M176M3%
Total Debt109K148M0%
FUNDAMENTALS RATINGS
VRBCF: Fundamental Ratings
VRBCF
OUTLOOK RATING
1..100
99
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MIRAVRBCF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
11%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Advances
ODDS (%)
Bullish Trend 15 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
20%
View a ticker or compare two or three
Ad is loading...
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCAUX11.230.06
+0.54%
Invesco Income Advantage U.S. Fund A
FSSKX84.220.40
+0.48%
Fidelity Advisor Stock Sel All Cp K
LSIRX41.130.08
+0.19%
ClearBridge Mid Cap IS
CUHAX10.94N/A
N/A
Victory US 500 Enh Vol Wtd Idx A
BCSAX8.14N/A
N/A
BlackRock Commodity Strategies Inv A

MIRA and

Correlation & Price change

A.I.dvisor tells us that MIRA and RHHBF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
-0.94%
RHHBF - MIRA
8%
Poorly correlated
+6.60%
ABBV - MIRA
8%
Poorly correlated
+1.60%
RHHVF - MIRA
8%
Poorly correlated
+0.08%
OGN - MIRA
8%
Poorly correlated
+0.82%
SNYNF - MIRA
7%
Poorly correlated
-0.43%
More

VRBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRBCF has been loosely correlated with RCDTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRBCF jumps, then RCDTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRBCF
1D Price
Change %
VRBCF100%
N/A
RCDTF - VRBCF
56%
Loosely correlated
N/A
OGN - VRBCF
1%
Poorly correlated
+0.82%
MIRA - VRBCF
1%
Poorly correlated
-0.94%
CSWYF - VRBCF
0%
Poorly correlated
N/A
JCRRF - VRBCF
-0%
Poorly correlated
N/A
More